NZCR

19/09/2025

If you missed the Attitude episode featuring Kiwi brothers Ollie & Ethan and their journey with Duchenne Muscular Dystrophy (DMD), you can still catch it on TVNZ+ and YouTube.

NZCR was one of the international sites involved in ‘Mission’- a groundbreaking clinical trial exploring treatment options for children living with DMD.

Check out The Parenting Files: Ollie & Ethan King from TVNZ+ or Youtube 👇

TVNZ - www.tvnz.co.nz/shows/attitude

YouTube - www.youtube.com/

13/09/2025

Tomorrow on TVNZ 1, don’t miss an inspiring episode of Attitude featuring “Mission”, the groundbreaking clinical trial that focused on treatment options for children with Duchenne Muscular Dystrophy (DMD).

The international study spanned 144 weeks and involved 144 participants across the globe.

NZCR were one of the international trial sites, with two young brothers from New Zealand who took part in the study doing remarkably well.

Tune in to watch their journey and the impact of cutting-edge research tomorrow, Sunday 14th September, at 12pm on TVNZ1.

12/09/2025

Tomorrow on TVNZ 1, watch an incredible episode of Attitude featuring “Mission”, the groundbreaking clinical trial that focused on treatment options for children with Duchenne Muscular Dystrophy (DMD).

NZCR were one of the international trial sites, with two young brothers from New Zealand who took part in the study doing remarkably well.

Tune in to watch their journey and the impact of innovative research tomorrow at 12pm on TVNZ1.

10/09/2025

We hosted a blood drive at our Auckland office with New Zealand Blood Service last week!

NZBlood does such important work, and it was a privilege to support their mission. A special thanks to those in the NZCR team who donated 👏

08/09/2025

Who can actually participate in a clinical trial?

Clinical trials are investigated in two groups - healthy volunteers and patients.

1️⃣ Healthy volunteers are generally healthy people, who aren’t on any long-term medications.

2️⃣ Patients are people who have the disease or condition that the potential new treatment is for.

Healthy volunteers are typically needed during early phase clinical trials while patients are needed for later phase clinical trials.

These trials help determine the safety, best dose, and how the body processes the potential new medication, as well as whether they work in treating the target disease.

If you’re considering a clinical trial, but still have questions - contact our team or check out our FAQs here 👉nzcr.co.nz/participants/faqs/

29/08/2025

Are you considering a vasectomy?

We’re currently looking for participants for an upcoming clinical trial investigating the effectiveness of an alternative, non-invasive form of long-term contraception for men – you could think of it like the male version of the pill.

If you’re male, aged between 28 – 70 years old, have a BMI of between 18 to 35 kg/m², and no known history of testicular disease, you might be a good fit for this study.

Our clinical trials involve an investigational drug and some study assessments. During your short stay you will have assessments done, including blood samples, to see how you’re responding to the study treatment. This is an investigational drug, and therefore it may have side effects which are unknown.

Interested? Visit our website to learn more and register: nzcr.co.nz/trial/latitude-ad/

26/08/2025

Our team recently attended the GP CME in Christchurch, where we had the pleasure of connecting with GPs and other healthcare professionals.

It was a fantastic opportunity for us and our sister company Optimal Clinical Trials to engage with experts in the medical community, share insights, and raise awareness about the important work we’re doing in the clinical trial industry.

If you’re a GP looking for more information about our current trials, or you’re thinking about clinical trials as a career path, check out our website: nzcr.co.nz

25/08/2025

We have incredible news to share! 🎉

NZCR are proud to have played a part in a truly groundbreaking moment in global medical research, the U.S. FDA’s accelerated approval of Modeyso™ (dordaviprone). This is the first and only treatment of its kind for an ultra-rare and devastating brain tumour affecting children and young adults.

At our Christchurch clinic, our NZCR team was honoured to be a key contributor, with hundreds of participants joining this study helping to advance the trial’s success.

This achievement shows the incredible talent and dedication within New Zealand’s clinical research community and the impact we can have on the world stage.

A special thank you to our participants who gave their time and commitment. You’ve helped make a real difference for patients and families worldwide💖

21/08/2025

Many of our participants continue working or studying while taking part in a clinical trial.

At our clinics, you’ll have free secure WiFi, sound-proof spaces, and a dedicated workspace, so you can stay productive and focused during your stay!

Curious about joining a clinical trial? Find out more here: nzcr.co.nz/current-trials/

18/08/2025

Do you:

👉 Have Type 2 Diabetes?

👉 Struggle to lose weight?

👉 Live in Auckland or Christchurch?

👉 Want to help advance global health?

If you’ve said yes to all the above, we welcome you to register for a clinical trial researching potential new medicines for obesity.

Your participation could help advance obesity research across the world. You can be reimbursed up to $5,500 before tax.

Clinical trials involve an investigational drug and some study assessments.

Interested? Apply here 👉 https://www.nzcr.co.nz/trial/nexus-part-2-chc-ad/

07/08/2025

Some of our trial participants in Auckland recently enjoyed a relaxing yoga session.

We believe that taking part in a clinical trial should be a positive experience, which is why our clinics offer unique activities and the chance to try something new.

Curious about joining a clinical trial? Find out more: https://loom.ly/nC1q3OY

02/08/2025

We are trialling a potential investigational medication designed to prevent HSV-2 Ge***al Herpes from causing recurrences.

Why participate?

👉 Contribute to potential scientific breakthroughs
👉 Explore potential new investigational medications for HSV-2

If you are 18 - 60 years old, in good health and living with HSV-2, you may be eligible to participate.

You can be reimbursed up to $3,900 before tax for participating in this study.

Other study inclusion and exclusion criteria also apply. Our clinical trials involve an investigational drug and some study assessments.

Interested? Apply here: https://loom.ly/3Obsjic

Study Information: Quail is trialling an investigational medication that is being developed for the suppression of recurrent ge***al herpes in people with Herpes Simplex Virus Type 2 (HSV-2) infection.